Charioteer specializes in the production of nucleoside antivirals and antipyretic analgesics, we are the largest producer of Naproxen and Acyclovir in China. Charioteer obtained Acyclovir COS in May 2004, Naproxen sodium FDA approval in July 2004, Naproxen FDA approval in January 2007. Integrated certification on ISO9001-ISO14001-OHSAS 18001 got in December 2004.
Main Competitive Advantages
N;
Postal Code
200135
Website
http://www.charioteer.com.cn
Trading Ability
Business type
N;
Main Sales Market
North America,Western Europe,Australasia,Asia,Middle East,Africa,